June 18, 2026 Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine
June 18, 2026 MENTOR Names Thomasina “Tomi” Hiers as Board Chair, Strengthening Philanthropic Leadership to Expand Opportunity for Young People
